SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-21-000043
Filing Date
2021-02-19
Accepted
2021-02-19 20:10:11
Documents
1
Period of Report
2021-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161378336580494.html 4  
1 FORM 4 wf-form4_161378336580494.xml 4 5646
  Complete submission text file 0001479290-21-000043.txt   7023
Mailing Address C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Joshi Abhay (Reporting) CIK: 0001359089 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 21657943

Mailing Address 7555 GATEWAY BLVD NEWARK CA 94560
Business Address 1222 DEMONBREUN STREET SUITE 1001 NASHVILLE TN 37203 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations